3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
12
Oropharyngeal Neoplasms
12
Prostatic Neoplasms
11
Head and Neck Neoplasms
7
Nasopharyngeal Carcinoma
6
Carcinoma, Squamous Cell
6
Esophageal Neoplasms
5
Rectal Neoplasms
4
Mouth Neoplasms
4
Laryngeal Neoplasms
4
Glioma
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Salivary Gland Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Papillomavirus Infections
2
Oligodendroglioma
2
Myelodysplastic Syndromes
2
Lymphatic Metastasis
2
Leukemia, Myeloid, Acute
2
Hypopharyngeal Neoplasms
2
Glioblastoma
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma
2
Astrocytoma
2
Anus Neoplasms
2
Virus Diseases
1
Vaginal Neoplasms
1
Interventions
Radiotherapy, Intensity-Modulated
1
Nimorazole
1
Cisplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
DNA Virus Infections
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled